Back to SO Soros Fund Management LLC

AZN

Showing 4 of 6 quarters

Position history for SOSoros Fund Management LLC's holdings in AstraZeneca PLC

No. Soros Fund Management exited its AZN (AstraZeneca) position in Q2 2025. Its Q1 2025 13F listed 2,742,498 shares worth $201.6M. Soros Fund Management first reported AZN in Q1 2024 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$206.7M

Total Shares Change

-2.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$137.36
0
2025-Q1
Decreased
2.7M
-13.1%
$201.6M3.0%$144.48
0
2024-Q4
Increased
3.2M
+19.0%
$206.8M3.1%$126.98
66
2024-Q3
Increased
2.7M
+8.2%
$206.7M3.0%$150.99
57

Other major holders of AZN: T. Rowe Price Associates, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used